- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.
Gilead, Pfizer, Abbvie stand to gain from Lilly and Incyte Rheumatoid Arthritis Setback.
Investors have turned away from biotech at a time when the sector is normally humming with presentations of new clinical data at springtime medical meetings.